The digital health industry has spent years overpromising on engagement. Brand teams have seen impressive launch metrics evaporate within weeks, and understandably, many have become skeptical.
Downloads are not patients. First sessions are not habits. So, when Dawn Health talks about engagement, we try to be specific.
Across Dawn Health’s companion solutions in specialty care, more than 40% of patients are still active after 30 days. In an industry where many health apps struggle to retain users beyond the first few weeks, that matters. It suggests that patients are finding value to come back and make the product part of their routine, rather than treating it as something to try once and forget.
At 90 days, 27% of patients remain engaged across several Dawn Health solutions. By that point, you’re no longer measuring curiosity. You’re measuring whether a product fits into the realities of living with a condition and managing treatment over time. Patients are returning to track symptoms, prepare for appointments, access educational content, or simply feel more supported between clinical interactions.
For pharmaceutical organisations, these numbers are about more than user experience. The question is no longer whether patients will download a digital solution. The real question is whether they will still be using it when they need it most. Sustained engagement is what turns digital health from an awareness initiative into something that can genuinely support patients and generate meaningful insights over time.
High engagement rarely comes from reminders or novelty alone. In Dawn Health's experience, it happens when digital products solve real problems and fit naturally into the patient journey. Patients return when a solution helps them navigate the moments that matter: understanding their treatment, preparing for conversations with their care team, or feeling more confident between visits.
In other words, patients engage when digital health becomes part of care rather than a destination in itself. That’s the standard Dawn Health designs for.
Dawn Health partners with leading pharmaceutical companies to develop regulated patient companion solutions across specialty care, including oncology, rare disease, immunology, and neuroscience.
